To be clear, I believe that funding for these bilateral programs and for UNRWA, funding which has been appropriated by C...
Holding a markup on this bill is a testament to the bipartisanship of this committee and the leadership of Chairman Royc...
I am glad that today we were able to consider a bipartisan piece of legislation that will bring some order and timelines...
If we give up our position as a donor, we also give up our influence.
The concern that I have is that we are not seemingly addressing that problem.
My concern is that you get these companies that come in that buy up a drug manufacturer, add no value, invest in no rese...
This is important to us.
I think in the area of de facto monopoly, it would be hard to identify an agency of government that actually has respons...
I think one can generally divide the pharmaceutical market into three categories.
Submitted by Hon. Sheldon Whitehouse, a U.S. Senator From Rhode Island
We have a President who has nominated--you know, we all understand Presidents nominate judges that reflect their politic...
What we are seeing in this current administration is the presentation of judicial candidates the lack of qualifications ...
I think that it is important to understand this request in the context in which we are currently living.
You are truly telling me that you are not going to answer this question, I should go knock on a different door in the sa...
So I want to be able to call up your legislative staff later on and say, actually, the Secretary agreed to give us this ...
trade wars are not good; they are very damaging. And for the State of Washington, they are very very damaging.
I would like to see what the economic projections are as to how that plays through.
I am trying to get that information to us.
